The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
- 作者: Motalkina M1, Kulyova S1,2, Alexeev S1, Zuzgin I1, Filatova L1, Zhabina A1, Zverkova A1, Ishmatova I1, Rjazankina A1,3, Artemyeva A1, Semiglazova T1,3
-
隶属关系:
- N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federation
- SBEI HPE St.Petersburg State Pediatric Medical University of the Ministry of Health of Russia
- SBEI HPE North-Western State Medical University named after I.I.Mechnikov
- 期: 卷 17, 编号 2 (2015)
- 页面: 54-56
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/27014
- ID: 27014
如何引用文章
全文:
详细
作者简介
M Motalkina
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federation
Email: margarita.motalk@mail.ru
аспирант НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
S Kulyova
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federation; SBEI HPE St.Petersburg State Pediatric Medical University of the Ministry of Health of Russiaд.м.н., старший научный сотрудник НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 194100, Russian Federation, Saint Petersburg, ul. Litovskaia, d. 2
S Alexeev
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationк.м.н., научный сотрудник НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
I Zuzgin
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationзав. химиотерапевтическим отд-нием гематологии, онкологии и трансплантации костного мозга НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
L Filatova
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationк.м.н., старший научный сотрудник НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
A Zhabina
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationк.м.н., научный сотрудник НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
A Zverkova
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationврач-гематолог НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
I Ishmatova
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationврач-гематолог НИИ онкологии им Н.Н. Петрова Минздрава России, Санкт-Петербург 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
A Rjazankina
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federation; SBEI HPE North-Western State Medical University named after I.I.Mechnikov191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41
A Artemyeva
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federationврач-патологоанатом НИИ онкологии им Н.Н. Петрова Минздрава России 197758, Russian Federation, Saint Petersburg, p. Pesochnyi, ul. Leningradskaia, d. 68
T Semiglazova
N.N. Petrov Research Institute of Oncology, of the Ministry of Health of the Russian Federation; SBEI HPE North-Western State Medical University named after I.I.Mechnikov191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41
参考
- Wuchter P, Ran D, Bruckner T et al. Poor mobilization of hematopoietic stem cells - definitions, incidence, risk factors, and impact on out - come of autologous transplantation. Biol Blood Marrow Transplant 2010; 16: 490-9.
- Nademanee A.P, Di Persio J.F, Maziarz R.T et al. Plerixafor plus granulocyte colony - stimulating factor vs. placebo plus granulocyte colony - stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Biol Blood Marrow Transplant 2012; 18 (10): 1564-72.
- Покровская О.С. Механизм действия и клиническая эффективность антагониста хемокинового рецептора CXCR4 плерик - сафора при мобилизации гемопоэтических стволовых клеток. Клин. онкогематология. 2012; 4: 371-9.
- Bakany S.M, Demirer T et al. Novel agents and approaches for stem cell mobilization in normal donors and patients. J Bone Marrow Transplant 2012; 47: 1154-63.
- Haioun C, Lepage E, Gisselbrecht C. Survival benefit of high dose therapy in poor risk aggressive non Hodgkins lymphoma: final analysis of the prospective LNH872 protocola groupe dEtude des lymphomes de I’Adulte study. J Clin Oncol 2000; 18 (16): 3025-30.
- Herbert K.E, Demosthenous L, Wiesner G et al. Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial. J Bone Marrow Transplant 2014; 49 (8): 1056-62.
- Gisselbrecht C, Lepage E, Molina T et al. Shortened first line high dose chemotherapy for patients poor prognosis aggressive lymphoma. J Clin Oncol 2002; 20 (10): 2472-9.